Paul Kruszka1, Dong Li2, Margaret H Harr3, Nathan R Wilson4, Daniel Swarr3, Elizabeth M McCormick3, Rosetta M Chiavacci2, Mindy Li3, Ariel F Martinez1, Rachel A Hart1, Donna M McDonald-McGinn3, Matthew A Deardorff3, Marni J Falk3, Judith E Allanson5, Cindy Hudson6, John P Johnson7, Irfan Saadi4, Hakon Hakonarson2, Maximilian Muenke1, Elaine H Zackai3. 1. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. 2. The Center for Applied Genomics, The Children's Hospital of Philadelphia, and the Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3. Division of Human Genetics, The Children's Hospital of Philadelphia, Clinical Genetics Center, and the Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 4. Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA. 5. Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada. 6. Shodair Children's Hospital, Helena, Montana, USA. 7. Shodair Children's Hospital, Helena, Montana, USA Clinical Genetics and Metabolism, Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Opitz G/BBB syndrome is a heterogeneous disorder characterised by variable expression of midline defects including cleft lip and palate, hypertelorism, laryngealtracheoesophageal anomalies, congenital heart defects, and hypospadias. The X-linked form of the condition has been associated with mutations in the MID1 gene on Xp22. The autosomal dominant form has been linked to chromosome 22q11.2, although the causative gene has yet to be elucidated. METHODS AND RESULTS: In this study, we performed whole exome sequencing on DNA samples from a three-generation family with characteristics of Opitz G/BBB syndrome with negative MID1 sequencing. We identified a heterozygous missense mutation c.1189A>C (p.Thr397Pro) in SPECC1L, located at chromosome 22q11.23. Mutation screening of an additional 19 patients with features of autosomal dominant Opitz G/BBB syndrome identified a c.3247G>A (p.Gly1083Ser) mutation segregating with the phenotype in another three-generation family. CONCLUSIONS: Previously, SPECC1L was shown to be required for proper facial morphogenesis with disruptions identified in two patients with oblique facial clefts. Collectively, these data demonstrate that SPECC1L mutations can cause syndromic forms of facial clefting including some cases of autosomal dominant Opitz G/BBB syndrome and support the original linkage to chromosome 22q11.2. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Opitz G/BBB syndrome is a heterogeneous disorder characterised by variable expression of midline defects including cleft lip and palate, hypertelorism, laryngealtracheoesophageal anomalies, congenital heart defects, and hypospadias. The X-linked form of the condition has been associated with mutations in the MID1 gene on Xp22. The autosomal dominant form has been linked to chromosome 22q11.2, although the causative gene has yet to be elucidated. METHODS AND RESULTS: In this study, we performed whole exome sequencing on DNA samples from a three-generation family with characteristics of Opitz G/BBB syndrome with negative MID1 sequencing. We identified a heterozygous missense mutation c.1189A>C (p.Thr397Pro) in SPECC1L, located at chromosome 22q11.23. Mutation screening of an additional 19 patients with features of autosomal dominant Opitz G/BBB syndrome identified a c.3247G>A (p.Gly1083Ser) mutation segregating with the phenotype in another three-generation family. CONCLUSIONS: Previously, SPECC1L was shown to be required for proper facial morphogenesis with disruptions identified in two patients with oblique facial clefts. Collectively, these data demonstrate that SPECC1L mutations can cause syndromic forms of facial clefting including some cases of autosomal dominant Opitz G/BBB syndrome and support the original linkage to chromosome 22q11.2. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Alice S Brooks; Marieke van Dooren; Jeannette Hoogeboom; Saskia Gischler; Patrick J Willems; Dick Tibboel Journal: Clin Dysmorphol Date: 2002-04 Impact factor: 0.816
Authors: N H Robin; G J Feldman; A L Aronson; H F Mitchell; R Weksberg; C O Leonard; B K Burton; K D Josephson; R Laxová; K A Aleck; J E Allanson; M L Guion-Almeida; R A Martin; L G Leichtman; R A Price; J M Opitz; M Muenke Journal: Nat Genet Date: 1995-12 Impact factor: 38.330
Authors: D M McDonald-McGinn; D A Driscoll; L Bason; K Christensen; D Lynch; K Sullivan; D Canning; W Zavod; N Quinn; J Rome Journal: Am J Med Genet Date: 1995-10-23
Authors: Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou Journal: Birth Defects Res Date: 2020-07-15 Impact factor: 2.344
Authors: K Taylor Wild; Tia Gordon; Elizabeth J Bhoj; Haowei Du; Shalini N Jhangiani; Jennifer E Posey; James R Lupski; Daryl A Scott; Elaine H Zackai Journal: Am J Med Genet A Date: 2020-09-21 Impact factor: 2.802
Authors: Nuno Maia; Maria J Nabais Sá; Nataliya Tkachenko; Gabriela Soares; Isabel Marques; Bárbara Rodrigues; Ana M Fortuna; Rosário Santos; Arjan P M de Brouwer; Paula Jorge Journal: Mol Syndromol Date: 2017-08-29
Authors: Dong Li; Michael E March; Paola Fortugno; Liza L Cox; Leticia S Matsuoka; Rosanna Monetta; Christoph Seiler; Louise C Pyle; Emma C Bedoukian; María José Sánchez-Soler; Oana Caluseriu; Katheryn Grand; Allison Tam; Alicia R P Aycinena; Letizia Camerota; Yiran Guo; Patrick Sleiman; Bert Callewaert; Candy Kumps; Annelies Dheedene; Michael Buckley; Edwin P Kirk; Anne Turner; Benjamin Kamien; Chirag Patel; Meredith Wilson; Tony Roscioli; John Christodoulou; Timothy C Cox; Elaine H Zackai; Francesco Brancati; Hakon Hakonarson; Elizabeth J Bhoj Journal: Hum Genet Date: 2021-04-03 Impact factor: 5.881
Authors: Everett G Hall; Luke W Wenger; Nathan R Wilson; Sraavya S Undurty-Akella; Jennifer Standley; Eno-Abasi Augustine-Akpan; Youssef A Kousa; Diana S Acevedo; Jeremy P Goering; Lenore Pitstick; Nagato Natsume; Shahnawaz M Paroya; Tamara D Busch; Masaaki Ito; Akihiro Mori; Hideto Imura; Laura E Schultz-Rogers; Eric W Klee; Dusica Babovic-Vuksanovic; Sarah A Kroc; Wasiu L Adeyemo; Mekonen A Eshete; Bryan C Bjork; Satoshi Suzuki; Jeffrey C Murray; Brian C Schutte; Azeez Butali; Irfan Saadi Journal: Hum Mol Genet Date: 2020-03-27 Impact factor: 5.121
Authors: Jeremy P Goering; Luke W Wenger; Marta Stetsiv; Michael Moedritzer; Everett G Hall; Dona Greta Isai; Brittany M Jack; Zaid Umar; Madison K Rickabaugh; Andras Czirok; Irfan Saadi Journal: Hum Mol Genet Date: 2021-12-17 Impact factor: 5.121